文献速递乳房整形与再造

糖尿病对乳房再造结局的影响:系统综述与Meta分析

Impact of diabetes on outcomes in breast reconstruction: A systematic review and meta-analysis.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2022-03-02

该系统综述与Meta分析检索EMBASE、PUBMED和MEDLINE至2020年11月1日,纳入65项研究,其中38项进入Meta分析,共151585例患者(9299例糖尿病)。糖尿病患者乳房再造术后总体并发症、手术并发症、植入物丢失、感染和坏死均显著高于非糖尿病患者,住院时间延长风险也更高。作者结论认为糖尿病增加乳房切除术后乳房再造并发症风险,需前瞻性研究确认。

要点

  • 糖尿病患者乳房再造术后总体并发症11.6% vs 非糖尿病5.6%(p<0.0001)。
  • 糖尿病患者手术并发症7.7% vs 非糖尿病3.3%(p<0.0001),住院时间延长风险更高(p=0.04)。
  • 亚组分析显示植入物丢失、感染和坏死在糖尿病患者中均显著更高。

核心结论

  • 糖尿病增加乳房切除术后乳房再造患者的并发症风险。
  • 需前瞻性研究确认再造前控制良好的糖尿病(包括合并辅助放疗者)是否降低围手术期风险。

研究设计与样本

  • 系统综述与Meta分析,按PRISMA指南进行,检索EMBASE、PUBMED和MEDLINE自建库至2020年11月1日的英文文献。
  • 65项研究符合纳入标准,其中38项提供数据进入Meta分析,共纳入151585例患者,其中9299例患糖尿病。

主要发现

  • 糖尿病患者总体并发症发生率为11.6%,非糖尿病者为5.6%(p<0.0001)。
  • 糖尿病患者手术并发症发生率为7.7%,非糖尿病者为3.3%(p<0.0001)。
  • 糖尿病患者住院时间延长的可能性高于非糖尿病患者(p=0.04)。
  • 亚组分析中,糖尿病患者植入物丢失率为2.5%,非糖尿病者为1.6%(p=0.0003)。
  • 糖尿病患者感染率为6.8%,非糖尿病者为2.5%(p<0.0001);坏死率为23.8%,非糖尿病者为6.5%(p=0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: As rates of breast cancer and type II diabetes increase, so does the number of women with diabetes undergoing breast reconstruction (BR). Patients with diabetes are at increased risk of postoperative complications. This meta-analysis seeks to evaluate the post-operative outcomes of women with diabetes who underwent BR following mastectomy. METHOD: This review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The EMBASE, PUBMED, and MEDLINE electronic databases were searched from inception to November 1, 2020 for studies published in English. Outcomes evaluated were overall complications, surgical complications, and longer hospital stay. Subgroup analysis investigated outcomes, such as implant/flap failure, infection, and necrosis. RESULTS: Sixty-five studies met our inclusion criteria and 38 provided data to be included in the meta-analysis. A total of 151,585 patients were included, of which 9299 had diabetes. Women with diabetes were more likely to experience overall complications (11.6% vs 5.6%; p<0.0001) and surgical complications (7.7% vs 3.3%; p<0.0001), and were more likely to have a prolonged hospital stay (p = 0.04) than women without diabetes. Subgroup analysis showed that implant loss (2.5% vs 1.6%; p = 0.0003), infection (6.8% vs 2.5%; p<0.0001) and necrosis (23.8% vs 6.5; p = 0.001) were significantly higher in women with diabetes. CONCLUSIONS: This study provides evidence that diabetes mellitus increases the risk of complications in patients with breast cancer undergoing BR after mastectomy. Prospective studies are required to establish whether diabetes that is well-controlled prior to reconstruction, including diabetes that is paired with adjuvant radiation therapy, reduces the perioperative risks.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Liu Q, Aggarwal A, Wu M, et al. Impact of diabetes on outcomes in breast reconstruction: A systematic review and meta-analysis. J Plast Reconstr Aesthet Surg. 2022. PMID: 35351394. doi:10.1016/j.bjps.2022.02.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。